APA (7th ed.) Citation

Alotaibi, S. H., Samaha, M. M., Helal, M. G., & El-Agamy, D. S. (2026). Ivabradine Attenuates Experimental Hepatic Fibrosis by Modulating Inflammatory and Apoptotic Signaling Pathways. Pharmaceuticals (14248247), 19(3), 504. https://doi.org/10.3390/ph19030504

Chicago Style (17th ed.) Citation

Alotaibi, Salman H., Mahmoud M. Samaha, Manar G. Helal, and Dina S. El-Agamy. "Ivabradine Attenuates Experimental Hepatic Fibrosis by Modulating Inflammatory and Apoptotic Signaling Pathways." Pharmaceuticals (14248247) 19, no. 3 (2026): 504. https://doi.org/10.3390/ph19030504.

MLA (9th ed.) Citation

Alotaibi, Salman H., et al. "Ivabradine Attenuates Experimental Hepatic Fibrosis by Modulating Inflammatory and Apoptotic Signaling Pathways." Pharmaceuticals (14248247), vol. 19, no. 3, 2026, p. 504, https://doi.org/10.3390/ph19030504.